T. Rowe Price Associates’s Amphenol APH Stock Holding History

T. Rowe Price Associates’s Portfolio APH Stock Details APH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.64B	Buy	64,022,672 +11,648,862	+22%	+$840M	0.56%	25
2026 Q1	$3.31B	Sell	52,373,810 -23,472,320	-31%	-$1.65B	0.38%	44
2025 Q4	$5.12B	Sell	75,846,130 -12,297,524	-14%	-$822M	0.55%	22
2025 Q3	$5.45B	Buy	88,143,654 +4,797,630	+6%	+$263M	0.58%	23
2025 Q2	$4.12B	Sell	83,346,024 -870,826	-1%	-$35.6M	0.47%	29
2025 Q1	$2.76B	Sell	84,216,850 -33,606,776	-29%	-$1.15B	0.34%	57
2024 Q4	$4.09B	Buy	117,823,626 +31,674,814	+37%	+$1.11B	0.47%	33
2024 Q3	$2.81B	Sell	86,148,812 -30,715,402	-26%	-$996M	0.32%	56
2024 Q2	$3.94B	Sell	116,864,214 -8,031,930	-6%	-$253M	0.47%	37
2024 Q1	$3.6B	Buy	124,896,144 +7,916,088	+7%	+$207M	0.44%	41
2023 Q4	$2.9B	Buy	116,980,056 +33,363,036	+40%	+$737M	0.39%	48
2023 Q3	$1.76B	Buy	83,617,020 +7,051,608	+9%	+$152M	0.26%	78
2023 Q2	$1.63B	Buy	76,565,412 +17,792,580	+30%	+$346M	0.23%	81
2023 Q1	$1.2B	Buy	58,772,832 +67,312	+0.1%	+$1.33M	0.18%	117
2022 Q4	$1.12B	Buy	58,705,520 +380,576	+0.7%	+$7.2M	0.18%	123
2022 Q3	$976M	Sell	58,324,944 -27,109,904	-32%	-$492M	0.16%	129
2022 Q2	$1.38B	Sell	85,434,848 -2,462,568	-3%	-$42.8M	0.17%	122
2022 Q1	$1.66B	Sell	87,897,416 -21,615,148	-20%	-$419M	0.17%	128
2021 Q4	$2.39B	Buy	109,512,564 +9,354,672	+9%	+$189M	0.22%	99
2021 Q3	$1.83B	Buy	100,157,892 +30,914,600	+45%	+$568M	0.17%	121
2021 Q2	$1.18B	Buy	69,243,292 +3,864,460	+6%	+$65.2M	0.11%	192
2021 Q1	$1.08B	Buy	65,378,832 +5,667,704	+9%	+$92.1M	0.11%	212
2020 Q4	$976M	Buy	59,711,128 +412,608	+0.7%	+$6.34M	0.1%	213
2020 Q3	$803M	Buy	59,298,520 +10,786,064	+22%	+$142M	0.09%	225
2020 Q2	$581M	Buy	48,512,456 +8,547,000	+21%	+$95.4M	0.07%	273
2020 Q1	$364M	Buy	39,965,456 +280,760	+0.7%	+$3.35M	0.06%	307
2019 Q4	$537M	Buy	39,684,696 +3,608,864	+10%	+$46.1M	0.07%	287
2019 Q3	$435M	Buy	36,075,832 +7,352,608	+26%	+$84.7M	0.06%	305
2019 Q2	$344M	Buy	28,723,224 +11,688,432	+69%	+$141M	0.05%	349
2019 Q1	$201M	Buy	17,034,792 +738,432	+5%	+$8.26M	0.03%	466
2018 Q4	$165M	Buy	16,296,360 +498,096	+3%	+$5.35M	0.03%	486
2018 Q3	$186M	Sell	15,798,264 -73,560	-0.5%	-$855K	0.03%	503
2018 Q2	$173M	Buy	15,871,824 +9,009,288	+131%	+$98M	0.03%	515
2018 Q1	$73.9M	Sell	6,862,536 -56,960	-0.8%	-$641K	0.01%	733
2017 Q4	$75.9M	Sell	6,919,496 -184,480	-3%	-$2.03M	0.01%	728
2017 Q3	$75.2M	Sell	7,103,976 -395,504	-5%	-$3.88M	0.01%	711
2017 Q2	$69.2M	Sell	7,499,480 -482,008	-6%	-$4.4M	0.01%	720
2017 Q1	$71M	Sell	7,981,488 -3,398,184	-30%	-$29.4M	0.01%	693
2016 Q4	$95.6M	Sell	11,379,672 -230,224	-2%	-$1.92M	0.02%	613
2016 Q3	$94.2M	Sell	11,609,896 -1,313,176	-10%	-$9.98M	0.02%	595
2016 Q2	$92.6M	Sell	12,923,072 -173,120	-1%	-$1.25M	0.02%	592
2016 Q1	$94.7M	Buy	13,096,192 +5,616,880	+75%	+$36.5M	0.02%	570
2015 Q4	$48.8M	Buy	7,479,312 +57,352	+0.8%	+$383K	0.01%	773
2015 Q3	$47.3M	Sell	7,421,960 -6,023,488	-45%	-$40.4M	0.01%	788
2015 Q2	$97.4M	Sell	13,445,448 -802,360	-6%	-$5.76M	0.02%	609
2015 Q1	$105M	Sell	14,247,808 -1,211,936	-8%	-$8.48M	0.02%	590
2014 Q4	$104M	Buy	15,459,744 +9,287,824	+150%	+$59.4M	0.02%	611
2014 Q3	$38.5M	Sell	6,171,920 -41,760	-0.7%	-$262K	0.01%	917
2014 Q2	$37.4M	Sell	6,213,680 -9,600	-0.2%	-$57.2K	0.01%	951
2014 Q1	$35.6M	Buy	6,223,280 +123,200	+2%	+$686K	0.01%	960
2013 Q4	$34M	Buy	6,100,080 +22,640	+0.4%	+$117K	0.01%	951
2013 Q3	$29.4M	Sell	6,077,440 -1,615,680	-21%	-$7.89M	0.01%	978
2013 Q2	$37.5M	Buy	+7,693,120	New	+$36.8M	0.01%	881

Other funds holding APH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates's APH Position: Q2 2026 in Review

T. Rowe Price Associates increased its Amphenol (APH) stake by 22% in Q2 2026, buying an estimated $840M and bringing the position to 64,022,672 shares worth $5.64B. The position accounts for 0.56% of the portfolio, ranked #25.

T. Rowe Price Associates first reported a position in APH in Q2 2013 and has held it in 53 quarters since. 2,326 funds tracked by Wall St. Rank hold APH as of Q2 2026.

T. Rowe Price Associates held 64,022,672 shares of Amphenol worth $5.64B as of Q2 2026.
T. Rowe Price Associates bought 11,648,862 Amphenol shares in Q2 2026, an estimated $840M.
Amphenol made up 0.56% of T. Rowe Price Associates's portfolio in Q2 2026, its #25 holding.
T. Rowe Price Associates first reported a position in Amphenol in Q2 2013 and has held it in 53 quarters since.
2,326 funds tracked by Wall St. Rank held Amphenol as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.